3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Reflex Sympathetic Dystrophy: new trials by email Literature Review of Reflex Sympathetic Dystrophy trials Research Report on Reflex Sympathetic Dystrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Placebo, Ethosuximide - Complex Regional Pain Syndromes | Phase 2 | Terminated | McGill University Health Centre/Research Institute of the McGill University Health Centre | 4 | 2008-09-01 | 2011-05-13 |
| Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 lenalidomide, Placebo - Complex Regional Pain Syndrome, Type I | Phase 2 | Terminated | Celgene Corporation | 184 | 2005-02-01 | 2013-08-28 |
| Neurotropin to Treat Chronic Neuropathic Pain Placebo, Neurotropin - Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome Type II | Phase 2 | Terminated | National Institute of Nursing Research (NINR) | 21 | 2000-09-01 | 2017-08-22 |
Complex Regional Pain Syndromes (3) · Agnosia (1) · Causalgia (1) · Chronic Pain (1) · Neuralgia (1) · Pain (1)
Autonomic Nervous System Diseases (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Neuromuscular Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Peripheral Nervous System Diseases (3) · Signs and Symptoms (3) · Pain (2) · Neurobehavioral Manifestations (1) · Perceptual Disorders (1)
Ethosuximide (1) · Lenalidomide (1) · neurotropin (1)
Celgene Corporation (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · National Institute of Nursing Research (NINR) (1)
United States (2) · Canada (1)
Donald C Manning, MD, PhD (1) · Leorey Saligan, PhD, CRNP (1) · Mark A Ware, MD (1)